Diagnostic Value of the International Society of Cardio-Oncology Definition for Suspected Immune Checkpoint Inhibitor-Associated Myocarditis
- PMID: 37042287
- PMCID: PMC10227269
- DOI: 10.1161/JAHA.122.029211
Diagnostic Value of the International Society of Cardio-Oncology Definition for Suspected Immune Checkpoint Inhibitor-Associated Myocarditis
Erratum in
-
Correction to: Diagnostic Value of the International Society of Cardio-Oncology Definition for Suspected Immune Checkpoint Inhibitor-Associated Myocarditis.J Am Heart Assoc. 2023 Aug 15;12(16):e027735. doi: 10.1161/JAHA.122.027735. Epub 2023 Aug 7. J Am Heart Assoc. 2023. PMID: 37548155 Free PMC article. No abstract available.
Keywords: cancer; cardio‐oncology; diagnosis; immunotherapy; myocarditis.
Figures

Similar articles
-
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians.Drug Saf. 2023 Sep;46(9):819-833. doi: 10.1007/s40264-023-01320-5. Epub 2023 Jun 21. Drug Saf. 2023. PMID: 37341925 Free PMC article. Review.
-
An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors.Biomolecules. 2021 May 22;11(6):785. doi: 10.3390/biom11060785. Biomolecules. 2021. PMID: 34067474 Free PMC article. Review.
-
Prospective screening for myocarditis in cancer patients treated with immune checkpoint inhibitors.J Cardiol. 2023 Jan;81(1):63-67. doi: 10.1016/j.jjcc.2022.07.009. Epub 2022 Aug 9. J Cardiol. 2023. PMID: 35953399
-
Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.Clin Res Cardiol. 2021 Jan;110(1):50-60. doi: 10.1007/s00392-020-01648-3. Epub 2020 Apr 15. Clin Res Cardiol. 2021. PMID: 32296970
-
[Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis].Zhongguo Fei Ai Za Zhi. 2021 Sep 20;24(9):668-672. doi: 10.3779/j.issn.1009-3419.2021.102.27. Epub 2021 Sep 15. Zhongguo Fei Ai Za Zhi. 2021. PMID: 34521189 Free PMC article. Chinese.
Cited by
-
Evolving cardiac biomarkers for immune checkpoint inhibitor related myocarditis in cancer patients.Int J Cardiol Heart Vasc. 2023 Oct 8;49:101278. doi: 10.1016/j.ijcha.2023.101278. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 37842144 Free PMC article. No abstract available.
-
Pembrolizumab-induced myocarditis, myositis, and myasthenia gravis overlap syndrome (IM3OS) treated with Efgartigimod: case report.Immunotherapy. 2025 Jun;17(8):561-566. doi: 10.1080/1750743X.2025.2517522. Epub 2025 Jun 13. Immunotherapy. 2025. PMID: 40510022
-
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment.Clin Res Cardiol. 2024 Aug;113(8):1263-1273. doi: 10.1007/s00392-024-02462-x. Epub 2024 May 28. Clin Res Cardiol. 2024. PMID: 38806821
-
Severe vs Nonsevere Immune Checkpoint Inhibitor-Induced Myocarditis: Contemporary 1-Year Outcomes.JACC CardioOncol. 2023 Dec 19;5(6):732-744. doi: 10.1016/j.jaccao.2023.09.004. eCollection 2023 Dec. JACC CardioOncol. 2023. PMID: 38205012 Free PMC article.
-
Immune Checkpoint Inhibitors and Their Cardiovascular Adverse Effects.Oncol Rev. 2023 Nov 17;17:11456. doi: 10.3389/or.2023.11456. eCollection 2023. Oncol Rev. 2023. PMID: 38045806 Free PMC article. Review.
References
-
- Lyon AR, López‐Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler‐Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, et al. 2022 ESC Guidelines on cardio‐oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio‐Oncology Society (IC‐OS). Eur Heart J. 2022;43:4229–4361. doi: 10.1093/eurheartj/ehac244 - DOI - PubMed
-
- Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, et al. Defining cardiovascular toxicities of cancer therapies: an International Cardio‐Oncology Society (IC‐OS) consensus statement. Eur Heart J. 2022;43:280–299. doi: 10.1093/eurheartj/ehab674 - DOI - PMC - PubMed
-
- Palaskas NL, Segura A, Lelenwa L, Siddiqui BA, Subudhi SK, Lopez‐Mattei J, Durand JB, Deswal A, Zhao B, Maximilian Buja L, et al. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail. 2021;23:1725–1735. doi: 10.1002/ejhf.2265 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical